InsiderGauge
Checking updates…
Dashboard

Dar Zavaininsider trades

In SEC Form 4 filings, Dar Zavain is listed as Director of Recursion Pharmaceuticals, Inc. (RXRX). Dar Zavain reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 2.

Companies and roles

CompanyRoleTransactionsLast filed
RXRXRecursion Pharmaceuticals, Inc.Director1Oct 2

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-02

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
RXRXRecursion Pharmaceuticals, Inc.Oct 1Oct 2A4,607$0.00$0245,371NoForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.